'Chemical architects' design metal-organic framework for drug delivery; Coating cloaks delivery devices from immune system;

> "Chemical architects" at the University of Pittsburgh have designed a metal-organic framework that forms porous structures capable of improved drug delivery, as well as gas storage and transport. More

> A "stealth character" coating for medical devices and drug-delivery systems could help cloak them, disguising the devices from the immune system. Story

> Researchers at the University of California, Berkeley, isolated a virus to target and deliver gene therapy to retinal cells in mice, a less invasive and more precise treatment for blindness. Report

> SurModics ($SRDX) entered a license agreement with Clinuvel Pharmaceuticals, providing Clinuvel with its biodegradable polymer implant technology for the treatment of sun-induced skin disorders. Release

> The FDA accepted IntelGenx's ($IGXT) new drug application for an oral thin-film migraine treatment, which disintegrates rapidly and releases the drug Rizatriptan. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.